Robeco Institutional Asset Management B.V.
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 1418773
ROTTERDAM, P7
Position in JAZZ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$28,340,963
+$5,072,311 QoQ
Shares Held
117,612
-4.4% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#76
of 640 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $992,672,242 across 15 Biotechnology names. JAZZ ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
460,602 | $287,203,771 | |
| 2 | INCY |
Incyte Corp
|
2,441,735 | $276,795,079 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
404,396 | $200,875,625 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
188,084 | $56,618,926 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,029,819 | $56,032,451 | |
| 6 | RPRX |
Royalty Pharma plc
|
911,586 | $51,112,627 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
117,612 | $28,340,963 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
408,215 | $23,358,062 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,340,963 | 117,612 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $23,268,652 | 123,082 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $15,920,330 | 93,649 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $12,707,892 | 96,418 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $12,831,499 | 120,915 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $26,531,972 | 213,709 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $24,790,587 | 201,304 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $18,645,131 | 167,356 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $19,906,959 | 186,517 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $36,620,926 | 304,110 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $38,330,982 | 311,634 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $36,767,690 | 284,052 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $26,853,389 | 216,612 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $19,419,893 | 132,713 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $19,699,000 | 123,652 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $18,007,479 | 135,100 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $1,523,905 | 9,768 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $2,018,105 | 12,964 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $1,589,060 | 12,473 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $4,019,843 | 30,872 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $19,472,186 | 109,616 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $26,111,653 | 158,859 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $38,620,214 | 233,991 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $38,233,512 | 268,136 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $30,014,686 | 272,020 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $17,961,977 | 180,088 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||